←
Loading live data…
PRICE
Loading…
REVENUE MIX
Total Revenue100%
COST
COGS38%
R&D + SG&A27%
Op Margin35%
FINANCIAL HEALTH
REVENUE
$50.1B
Growth
7%
Gross M.
62%
P/E
26.7
EV/EBITDA
24.6
Net M.
29%
FCF M.
10%
D/E
1.41
Op M.
35%
PLUG INTO YOUR DCF
Historical growth
7.8%
Analyst 5y growth
—
Forward P/E
25.6
PEG ratio
4.20
Trailing EPS
$3.40
Forward EPS
$3.50
🚩 RED FLAG SCANNER — 10-K RISK FACTORS, YEAR OVER YEAR
TAM
SIZE
—
CAGR
—
Market-size estimates aren't available for this stock right now — see Financial Health and Risk Assessment below for a fundamentals-based read instead.
RISK ASSESSMENT
HIGTrading above a mechanical base-case DCF estimate of $62.26 (default assumptions) — priced for continued strong execution.
MEDDebt/equity of 1.41 — moderate leverage.
LOWRevenue growing 7% YoY — steady, unspectacular growth.
🐂 BULL
KO shows revenue grew +6.7% YoY, 35% operating margin, 42% ROE, a healthy 10% free cash flow margin — a business converting growth into real profit.
🐻 BEAR
At a P/E of 26.7 and EV/EBITDA of 24.6, the stock is priced for continued execution — any deceleration in growth or margin compression would likely pressure the multiple.
AI-powered data, computed by TreasureX · May contain inaccuracies
⚠️
All values, scores, and figures here are computed from your own assumptions and public data, for educational purposes only. This is not investment advice — TreasureX does not recommend buying or selling any security. Results change with your inputs. Please do your own research and use your own judgement before making any investment decision.